SETIAWAN, S. I.; ASCOBAT, P. ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA. International Journal of Applied Pharmaceutics, [S. l.], v. 11, n. 6, p. 80–83, 2019. DOI: 10.22159/ijap.2019.v11s6.33551. Disponível em: https://journals.innovareacademics.in/index.php/ijap/article/view/33551. Acesso em: 21 nov. 2024.